Document:

EX-10.33

 Exhibit 10.33 

FORM OF AMENDED AND RESTATED EMPLOYMENT AGREEMENT 

This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made as of _______, 2022 by and between SeaStar
Medical Holding Corporation (the “Company”), and Caryl Baron (“Executive”). 
 WHEREAS, SeaStar Medical, Inc. and
Executive previously entered into an employment agreement dated March 22, 2020 (“Prior Employment Agreement”); 

WHEREAS, SeaStar Medical, Inc. has entered into an Agreement and Plan of Merger (the “Merger Agreement”) with LMF Acquisition
Opportunities, Inc. (“LMAO”), pursuant to which SeaStar Medical, Inc. expects to complete a business combination with LMAO and become a publicly traded company listed on NASDAQ Stock Market (the “SPAC Merger”); 

WHEREAS, upon completion of this SPAC Merger, SeaStar Medical, Inc. will become a wholly owned subsidiary of LMAO, and LMAO will be
renamed “SeaStar Medical Holding Corporation;” 
 WHEREAS, the Company and Executive now desire to amend the Prior
Employment Agreement to transfer Executive’s employment relationship from SeaStar Medical, Inc. to the Company, reflect changes to the Executive’s compensation, severance benefits, and to make certain other changes in connection with and
contingent upon the closing of the SPAC Merger; and 
 WHEREAS, this Agreement shall become effective as of and contingent upon the
closing of the SPAC Merger and supersedes and replaces all previous employment agreements or other written or oral agreements between Executive and either SeaStar Medical, Inc. or the Company, including the Prior Employment Agreement, with respect
to the subject matter covered under this Agreement. 
 NOW, THEREFORE, in consideration of the promises and mutual covenants
contained herein, the parties agree as follows: 
 1. Employment Period and Effective Date. The effective date
of this Agreement shall be the closing date of the SPAC Merger (the “Effective Date”). Following the Effective Date, Executive’s employment with the Company pursuant to this Agreement shall be “at will,” and either the
Company or Executive may terminate the employment relationship at any time in accordance with the provisions of Paragraph 7. The period during which Executive is in fact employed by the Company pursuant to this Agreement shall constitute the
“Employment Period” hereunder, and shall commence on the Effective Date. 
 2. Duties and Responsibilities. 

A. During the Employment Period, Executive shall serve as the Company’s Finance Controller (“Finance Controller”), with a
principal office in the Company’s Denver, Colorado location, subject to reasonable business travel, and shall report to the Company’s Chief Executive Officer (“CEO”). Executive agrees to perform in good faith and to the best of
her ability all services that may be required of Executive hereunder and to be available to render such services at all reasonable times and places in accordance with such directions and requests as may be made from time to time by the Company or
Board of Directors of the Company (the “Board”). 

 B. Executive is expected and agrees to devote her full working time and attention to the
business of the Company, and will not render services to any other business without the prior approval of the Board, directly or indirectly, engage or participate in any business that is competitive in any manner with the business of the Company.
Executive may invest in up to one percent (1%) of the outstanding securities of any publicly-held corporation without approval of the Company, subject to any limits or requirements of the Company’s corporate governance policies (as in effect
from time to time). Moreover, in the sole discretion of, and upon approval from, the CEO, Executive may participate in other board or advisory positions that do not in any way negatively impact or conflict with the Company or Executive’s
employment with the Company. The Executive agrees that Executive shall disclose any such directorship to the Board prior to the Effective Time or prior to commencing any such position, as applicable. 

C. Executive understands and agrees that she must fully comply with the Company’s standard operating policies, procedures, and practices
that are from time to time in effect during the term of her employment. 
 3. Compensation. 

A. During the Employment Period, Executive shall receive an annual gross base salary in the amount of Two Hundred Ten Thousand Dollars
($210,000), to be paid in periodic installments in accordance with the Company’s normal payroll procedures, less all applicable withholdings and deductions (“Base Salary”). 

B. During the Employment Period, Executive will be eligible to participate in an executive annual cash bonus plan to the extent established by
the Compensation Committee of the Board (the “Compensation Committee”) from time to time for similarly-situated executives of the Company. The Executive’s participation in any such plan shall be governed by the terms and conditions of
such plan as then in effect and the decision to provide any bonus opportunity shall be in the sole and absolute discretion of the Compensation Committee. 

4. Equity. Following the Effective Date, subject to approval of the Board, the Company will grant Executive an
option under the Company’s equity incentive plan then in effect (the “Plan”) to purchase a number of shares of the Company’s Common Stock (the “Option”), which together with Executive’s existing equity in the
Company (including restricted stock units covering shares of Company Common Stock and options to purchase shares of Company Common Stock, in each case whether vested or unvested), will equal 0.25% of the issued and outstanding capital stock of the
Company, calculated on a fully-diluted basis, as of the Effective Date. The Option will have a per share exercise price equal to the fair market value of the Company’s common stock on the date of grant and will be immediately exercisable,
subject to the Company’s right of repurchase of unvested shares upon Executive’s termination of employment. 25% of the shares of common stock subject to the Option will vest upon the first anniversary of the Effective Date, and the
remaining 75% of such shares shall vest monthly in thirty six (36) equal monthly installments thereafter; vesting shall cease upon Executive’s cessation of employment with the Company. The Option will be subject to the terms and
conditions of the Plan and the written Stock Option Agreement governing the Option. Notwithstanding the foregoing (i) in the event of certain separations from service from the Company, the vesting of the Option will be accelerated to the extent
set forth in Paragraph 8 below; and (ii) Executive shall have up to twelve (12) months following any termination of employment (other than termination for Cause (as defined below)) to exercise any then-vested outstanding options to
purchase Company Common Stock (and understands and assumes the burden for any modified tax treatment thereunder associated with the extended exercise period). 

  
 2 

 5. Benefits; Reimbursement. 

A. Health Insurance. During the Employment Period, Executive shall be eligible to participate in all employee benefits
and benefit plans generally made available to the Company’s employees from time-to-time, including, but not limited to, medical, dental, vision and long-term
disability insurance benefits and arrangements, subject to the terms, conditions and relevant qualification criteria for such benefits and benefit plans. The Company, in its discretion, may change from time-to-time the employee benefits and benefit plans it generally makes available to its employees. 

B. Expense Reimbursement. During the Employment Period, Executive shall be entitled to reimbursement for all reasonable
and necessary expenses incurred by Executive associated with the conduct of the Company’s business in accordance with the Company’s policies. Such reimbursements shall be subject to the Company’s then-existing policies and procedures
for reimbursement of business expenses, but in any event shall include submission of written requests for reimbursement within no more than thirty (30) days of incurring the expense, accompanied by vouchers, receipts or other details of such
expenses in the form required by the Company, sufficient to substantiate a deduction for such business expenses under all applicable rules and regulations of federal and state taxing authorities. If such expense qualifies for reimbursement, then the
Company will reimburse Executive for that expense in accordance with existing expense reimbursement policies and practices. 
 C.
Vacation, Sick, and Holiday Pay. During the Employment Period, Executive shall be entitled to earn or receive vacation, sick, and holiday pay pursuant to the terms of the Company’s generally applicable employee policies, as
may exist from time to time. 
 6. Proprietary Information and Inventions Agreement. As a condition of
employment and the benefits provided by this Agreement, Executive is required to timely execute and return the Company’s form of Proprietary Information and Inventions Agreement, attached hereto as Exhibit A (the
“PIIA”). Executive shall at all times remain subject to the terms and conditions of such PIIA, and nothing in this Agreement shall supersede, modify, or affect Executive’s obligations, duties, and responsibilities thereunder. 

7. Termination of Employment. Executive’s employment pursuant to this Agreement is “at will” and
may be terminated by either party at any time, with or without cause, in accordance with the following provisions: 
 A. Upon cessation of
Executive’s employment for any reason, Executive, or his estate if applicable, shall be paid any unpaid Base Salary earned under Paragraph 3 for services rendered through the date of such termination. 

B. Executive may voluntarily separate from her employment under this Agreement at any time and for any reasons, but shall give the Company at
least thirty (30) days prior written notice of such resignation. 
 C. The Company may terminate Executive’s employment with or
without Cause under this Agreement at any time by providing notice of such termination to Executive. Such termination shall be effective immediately upon Executive’s receipt of such notice, unless otherwise indicated by the notice. 

  
 3 

 8. Severance Benefits 

A. Resignation, Termination for Cause, or Death. If Executive resigns, is terminated for Cause (as defined below), or dies, then she
(or her estate, as applicable) shall only be entitled to payment of her Base Salary payable through the date of termination, but shall not otherwise be entitled to any severance or separation pay from the Company. 

B. Termination Without Cause. If the Company terminates Executive’s employment without Cause (as defined below) then, subject to
Executive timely executing, returning, and not revoking a separation agreement and general release of claims acceptable to the Company in its discretion (“Separation Agreement”), the Company will pay Executive as severance an amount
equivalent to nine (9) months of Executive’s Base Salary in effect on the termination date (“Severance Payment”) and, subject to Executive timely and properly enrolling in continued health coverage under the Consolidated Omnibus
Budget Reconciliation Act (“COBRA”), an additional cash amount equal to the monthly premium cost of Executive’s coverage under the Company’s health plan, plus 2% of such amount (“Benefits Payment”), both payable in
equal installments as salary continuation payments for a nine (9)-month period following the termination date (or, with respect to the Benefits Payment, such shorter period as described below) (“Severance Period”), in accordance with the
Company’s normal payroll dates and practices, the first installment of which shall be made on the Company’s first regular payroll period following the sixtieth (60th) day after the termination date (and will include any Severance Payment
and Benefits Payment installment(s) that would have otherwise been paid during the period following the termination date through the date of the first Severance Payment and Benefits Payment installment); provided that, Executive has timely executed
and delivered the Separation Agreement and the Separation Agreement has become irrevocable by its terms as of such date. Notwithstanding the foregoing, the Severance Payment shall be reduced by any amounts payable to Executive as a result of any
subsequent employment or service to another employer or service recipient other than the Company during the Severance Period and, if Executive obtains another employment or service arrangement prior to the end of the Severance Period that offers
Executive health coverage, then the Benefits Payment shall immediately cease as of such date Executive is eligible for such health coverage. Executive hereby agrees to notify the Company within five (5) business days of becoming aware that
Executive will begin employment or provide service to another employer or service recipient. Notwithstanding the foregoing, the Company reserves the right to restructure the Benefits Payment at any time and in any manner necessary to comply with
federal income tax law, as determined by the Company in its sole discretion. The Severance Payment and Benefits Payment shall be in lieu of any other severance benefits under any Company plan, program or policy, and Executive waives her rights, if
any, to have such payment taken into account in computing any other vested benefits payable to or on behalf of Executive, by the Company, if any. 

C. Termination Without Cause Following Change in Control. If the Company terminates Executive’s employment without Cause (as
defined below) within twelve (12) months following a Change of Control (as defined below), then, in addition to the Severance Payment set forth above, and similarly subject to Executive timely executing, returning, and not revoking the
Separation Agreement, then 100% of any remaining balance of the Option shall immediately vest. 

  
 4 

 (1) For purposes of this Agreement, “Cause” means, in the Company’s
reasonable good faith belief that one of the following have occurred: 
 (i) Executive’s commission of any act of fraud, embezzlement,
dishonesty, or sexual harassment (or attempt to do any of the foregoing); 
 (ii) Executive’s refusal or failure to comply in any
material respect with any lawful direction of or written policies or procedures of the Company, or the Board (including, without limitation, the Company’s anti-discrimination and harassment policies and the Company’s drug and alcohol
policy); 
 (iii) any unauthorized use or disclosure by Executive of confidential information or trade secrets of the Company (or any
parent or subsidiary of the Company); or 
 (iv) any other gross negligence or misconduct by Executive adversely affecting the business or
affairs of the Company (or any parent or subsidiary of the Company) in a material manner. 
 (v) 

(2) For purposes of this Agreement, “Change of Control” means a change in ownership or control of the Company effected through any
of the following transactions: 
 (i) a merger, consolidation or other reorganization approved by the Company’s stockholders, unless
securities representing fifty percent (50%) or more of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same
proportion, by the persons who beneficially owned the Company’s outstanding voting securities immediately prior to such transaction; 

(ii) a sale, transfer, or other disposition of all or substantially all of the Company’s assets; 

(iii) the closing of any transaction or series of related transactions pursuant to which any person or any group of persons comprising a
“group” within the meaning of Rule 13d-5(b)(1) of the Securities Exchange Act of 1934, as amended (the “1934 Act”) (other than the Company or a person that, prior to such transaction or
series of related transactions, directly or indirectly controls, is controlled by or is under common control with, the Company) acquires directly or indirectly (whether as a result of a single acquisition or by reason of one or more acquisitions
within the twelve (12)-month period ending with the most recent acquisition) beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing (or convertible into or exercisable
for securities possessing) fifty percent (50%) or more of the total combined voting power of the Company’s securities (as measured in terms of the power to vote with respect to the election of Board members) outstanding immediately after the
consummation of such transaction or series of related transactions, whether such transaction involves a direct issuance from the Company or the acquisition of outstanding securities held by one or more of the Company’s existing stockholders; or

  
 5 

 (iv) a change in the composition of the Board over a period of twelve (12) consecutive
months or less such that a majority of the Board members ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who either (A) have been Board members continuously since the beginning of such
period or (B) have been elected or nominated for election as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the time the Board approved such election or
nomination. 
 9. Benefit Limit. The benefit limitations of this Paragraph shall be applicable in the event
Executive receives any benefits under this Agreement that are deemed to constitute parachute payments under Code Section 280G. In the event that any payments to which Executive becomes entitled in accordance with the provisions of this
Agreement would otherwise constitute a parachute payment under Code Section 280G, then such payments will be subject to reduction to the extent necessary to assure that Executive receives only the greater of (i) the amount of those
payments which would not constitute such a parachute payment or (ii) the amount which yields Executive the greatest after-tax amount of benefits after taking into account any excise tax imposed on the
payments provided to Executive under this Agreement (or on any other benefits to which Executive may become entitled in connection with any change in control or ownership of the Company or the subsequent termination of her employment with the
Company) under Code Section 4999. 
 10. Delayed Commencement of Benefits. Notwithstanding any provision to
the contrary in this Agreement, no payments or benefits that are subject to the restrictions of Code Section 409A to which Executive becomes entitled under this Agreement shall be made or paid to Executive prior to the earlier of
(i) the expiration of the six (6)-month period measured from the date of her separation from service with the Company or (ii) the date of her death, if Executive is deemed at the time of such separation from service a “key
employee” within the meaning of that term under Code Section 416(i) and such delayed commencement is otherwise required in order to avoid a prohibited distribution under Code Section 409A(a)(2). Upon the expiration of the applicable
Code Section 409A(a)(2) deferral period, all payments deferred pursuant to this Paragraph shall be paid in a lump sum to Executive, and any remaining payments due under this Agreement shall be paid in accordance with the normal payment dates
specified for them herein. 
 11. Compliance with Section 409A. It is the
intent of the Company and Executive that the provisions of this Agreement comply with all applicable requirements of Code Section 409A. Accordingly, to the extent any provisions of this Agreement would otherwise contravene one or more
requirements or limitations of Code Section 409A, then the Company and Executive shall, within the remedial amendment period provided under the Treasury Regulations issued under Code Section 409A, effect through mutual agreement the
appropriate amendments to those provisions which are necessary in order to bring the provisions of this Agreement into compliance with Code Section 409A. If any payment under this Agreement is subject to Code Section 409A,
(i) distributions shall only be made in a manner and upon an event permitted under Code Section 409A, (ii) payments to be made upon a termination of employment or service shall only be made upon a “separation from service”
under Code Section 409A, (iii) each installment of a payment shall be treated as a separate payment for purposes of Code Section 409A, (iv) if any payment is subject to the execution of a Separation Agreement, in no event shall
the timing of Executive’s execution of the Separation Agreement result in Executive designating, directly or indirectly, the calendar year of payment, and if such a payment that is subject to execution of the Separation Agreement could be made
in more than one taxable year, payment shall be made in the later taxable year, and (v) any reimbursements of costs and expenses or in-kind benefits shall be made on or before the last calendar day of the
year following the calendar year in which the expense occurred, unless otherwise permitted by Section 409A. 

  
 6 

 12. Cessation of Benefits. In the event of a breach by Executive
of any of her obligations of this Agreement or under the PIIA, she shall cease to be entitled to any further benefits under this Agreement. In no event shall Executive be entitled to any severance benefits under this Agreement if (i) her
employment ceases by reason of a termination for Cause, or (ii) she voluntarily resigns from employment with the Company. 
 13.
Successors and Assigns. This Agreement and all rights hereunder are personal to Executive and may not be transferred or assigned by Executive at any time. The Company may assign its rights, together with its obligations
hereunder, to any parent, subsidiary, affiliate, or successor, or in connection with any sale, transfer, or other disposition of all or substantially all of its business and assets, provided, however, that any such assignee assumes the
Company’s obligations hereunder. 
 14. Notices. 

A. Any and all notices, demands or other communications required or desired to be given hereunder by any party shall be in writing and shall
be validly given or made to another party if delivered either personally or if deposited in the United States mail, certified or registered, postage prepaid, return receipt requested. If such notice, demand, or other communication shall be delivered
personally, then such notice shall be conclusively deemed given at the time of such personal delivery. 
 B. If such notice, demand, or
other communication is given by mail, such notice shall be conclusively deemed given forty-eight (48) hours after deposit in the United States mail addressed to the party to whom such notice, demand or other communication is to be given as
hereinafter set forth: 
 To the Company: 

SeaStar Medical Holding Corporation 

3513 Brighton Blvd 
 Ste 410

 Denver, CO 80516 
 Attn:
Chief Executive Officer 
 To Executive: 

Caryl Baron 

[                ] 

C. Any party hereto may change its address for the purpose of receiving notices, demands and other communications as herein provided by a
written notice given in the manner aforesaid to the other party hereto. 

  
 7 

 15. General Creditor Status. The benefits to which Executive may
become entitled under this Agreement shall be paid, when due, from the Company’s general assets, and no trust fund, escrow arrangement or other segregated account shall be established as a funding vehicle for such payments. Accordingly,
Executive’s right (or the right of the executors or administrators of Executive’s estate) to receive such benefits shall at all times be that of a general creditor of the Company and shall have no priority over the claims of other general
creditors. 
 16. Governing Documents. This Agreement, together with (i) any equity award agreements, and
(ii) the PIIA, shall constitute the entire agreement and understanding of the Company and Executive with respect to the terms and conditions of Executive’s employment with the Company and the eligibility for any potential severance
payments and consulting payments following separation from employment with the Company, and this Agreement shall supersede all prior and contemporaneous written or verbal agreements and understandings between Executive and SeaStar Medical, Inc. or
the Company relating to such subject matter, including, without limitation, the Prior Agreement. This Agreement, including but not limited to the at-will nature of the employment relationship as reflected
herein, may only be amended by written instrument signed by Executive and the CEO. 
 17. Governing Law. The
provisions of Agreement shall be construed and interpreted under the laws of the State of Colorado applicable to agreements executed and wholly performed within the State of Colorado. If any provision of this Agreement as applied to any party or to
any circumstance should be adjudged by a court of competent jurisdiction to be void or unenforceable for any reason, the invalidity of that provision shall in no way affect (to the maximum extent permissible by law) the application of such provision
under circumstances different from those adjudicated by the court, the application of any other provision of this Agreement, or the enforceability or invalidity of this Agreement as a whole. Should any provision of this Agreement become or be deemed
invalid, illegal or unenforceable in any jurisdiction by reason of the scope, extent or duration of its coverage, then such provision shall be deemed amended to the extent necessary to conform to applicable law so as to be valid and enforceable or,
if such provision cannot be so amended without materially altering the intention of the parties, then such provision will be stricken, and the remainder of this Agreement shall continue in full force and effect. 

18. Arbitration. 

A. Except as provided herein and the PIIA, each party hereto agrees that any and all disputes which arise out of or relate to Executive’s
employment, the termination of Executive’s employment, or the terms of this Agreement shall be resolved through final and binding arbitration. Such arbitration shall be in lieu of any trial before a judge and/or jury, and Executive and the
Company expressly waive all rights to have such disputes resolved via trial before a judge and/or jury. Such disputes shall include, without limitation, claims for breach of contract or of the covenant of good faith and fair dealing, claims of
discrimination, claims under any federal, state, or local law or regulation now in existence or hereinafter enacted and as amended from time to time concerning in any way Executive’s employment with the Company or its termination. The only
claims not covered by this Employment Agreement to arbitrate disputes, which shall instead be resolved pursuant to applicable law, are: (i) claims for benefits under the unemployment insurance benefits; (ii) claims for workers’
compensation benefits under any of the Company’s workers’ compensation insurance policy or fund; (iii) claims under the National Labor Relations Act; and (iv) claims that may not be arbitrated as a matter of law. 

  
 8 

 B. Arbitration will be conducted in Colorado. Arbitration shall be conducted in accordance
with the Federal Arbitration Act (“FAA”) and the National Rules for the Resolution of Employment Disputes of the American Arbitration Association (“AAA Rules” available at www.adr.org) or any other discovery required by
applicable law in arbitration proceedings, including, but not limited to, discovery available under the applicable state and/or federal arbitration statutes. Also, to the extent that any of the AAA Rules or anything in this arbitration section
conflicts with any arbitration procedures required by applicable law, the arbitration procedures required by applicable law shall govern. 

C. During the course of arbitration, the Company will bear the cost of (i) the arbitrator’s fee, and (ii) any other expense or
cost Executive would not be required to bear if Executive were free to bring the dispute or claim in court. Each party shall bear such party’s own attorneys’ fees incurred in connection with the arbitration. The arbitrator will not have
authority to award attorneys’ fees unless a statute or contract at issue in the dispute authorizes the award of attorneys’ fees to the prevailing party. In such case, the arbitrator shall have the authority to make an award of
attorneys’ fees as required or permitted by the applicable statute or contract. 
 D. The arbitrator shall issue a written award that
sets forth the essential findings of fact and conclusions of law on which the award is based. The arbitrator shall have the authority to award any relief authorized by law in connection with the asserted claims or disputes. The arbitrator’s
award shall be subject to correction, confirmation, or vacation, as provided by applicable law setting forth the standard of judicial review of arbitration awards. Judgment upon the arbitrator’s award may be entered in any court having
jurisdiction thereof. 
 E. This arbitration provision does not prohibit Executive from pursuing an administrative claim with a local,
state, or federal administrative agency such as the Equal Employment Opportunity Commission, but this arbitration agreement does prohibit Executive from seeking or pursuing court action regarding any such claim. 

19. Counterparts. This Agreement may be executed in more than one counterpart, each of which shall be deemed an
original, but all of which together shall constitute but one and the same instrument. 
 20. Construction. The
language of this Agreement shall be construed as to its fair meaning, and not strictly for or against either party. Any rule of construction that any ambiguities in a contract shall be construed against the drafter of a contract shall not apply.

 21. Indemnification. Executive will be provided indemnification to the maximum extent permitted by the
Company’s and its subsidiaries’ and affiliates’ Articles of Incorporation or Bylaws, but on terms no less favorable than provided to any other Company executive officer or director and subject to the terms of any separate written
indemnification agreement. 
 [SIGNATURE PAGE FOLLOWS] 

  
 9 

 IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the day and year
written above. 
  

			
	SEASTAR MEDICAL HOLDING CORPORATION
		
	By:	 	  

		
	Title:	 	  

	
	EXECUTIVE
	
	  

	
	Caryl Baron

  

  
 10EX-4.1

 Exhibit 4.1 

Form 540 Prescribed by: 
  

			
	

	    	 Toll Free: 877.767.3453   |   Central Ohio: 614.466.3910

 
 OhioSoS.gov   |   business@OhioSoS.gov

 
 File online or for more information: OhioBusinessCentral.gov

  
  

 
 Certificate of Amendment 

(For-Profit, Domestic Corporation) 

Filing Fee: $50 
 Form
Must Be Typed 
  

					
	Check appropriate box:
	 
	
☒   Amendment to existing Articles of Incorporation
(125-AMDS)

	
☐   Amended and Restated Articles (122-AMAP) - The
following articles supersede the existing articles and all amendments thereto.

  

							
	Complete the following information:	  	 	  	 
	 	 	 
	 Name of Corporation
	  	KEYCORP	  	 
	 			 
	 	  		  		  	 
	 	 		 
	 Charter Number
	  	276604	  		  	 
	 			 
	 	  	 	  	 	  	 

  

			
	Check one box below and provide information as required:	 	

  

					
	 	 
	
☐   The articles are hereby amended by the Incorporators. Pursuant to Ohio Revised
Code section 1701.70 (A), incorporators may adopt an amendment to the articles by a writing signed by them if initial directors are not named in the articles or elected and before subscriptions to shares have been received.
	 	 
	 	 
	
☒   The articles are hereby amended by the Directors. Pursuant to Ohio Revised Code
section 1701.70(A), directors may adopt amendments if initial directors were named in articles or elected, but subscriptions to shares have not been received. Also, Ohio Revised Code section
1701.70(B) sets forth additional cases in which directors may adopt an amendment to the articles.
	 	 
	 	 	 
	 The resolution was adopted pursuant to Ohio Revised Code
section 1701.70(B) (In this space insert the number 1 through 10 to provide basis for adoption.)
	 	1701.70(B)(1)	 	 
	  	 	  	 	  
	 	 
	
☐   The articles are hereby amended by the Shareholders pursuant to Ohio Revised Code
section 1701.71.
	 	 
	 	 
	
☐   The articles are hereby amended and restated pursuant to Ohio Revised Code section
1701.72.
	 	 

  

					
	Form 540	  	Page 1 of 2	  	Last Revised: 06/2019

	
	A copy of the resolution of amendment is attached to this document.
	 
	Note: If amended articles were adopted, they must set forth all
provisions required in original articles except that articles amended by directors or shareholders need not contain any statement with respect to initial stated capital. See Ohio Revised Code section 1701.04 for required provisions.

  

							
	
By signing and submitting this form to the Ohio Secretary of State, the undersigned hereby certifies that he or she has the requisite authority to execute
this document.
  

	Required	 		 	

	  	 
	Must be signed by all incorporators, if amended by incorporators, or an authorized officer if amended by directors or shareholders, pursuant to Ohio Revised Code
section 1701.73(B) and (C).	 		 	 Signature
  
	  	 
	 	 	  	 
	 	 By (if applicable)
  
	  	 
	 	 		 	Carrie A. Benedict, Assistant Secretary of KeyCorp	  	 
	If authorized representative is an individual, then they must sign in the “signature” box and print their name in the “Print Name” box.	 		 	 Print Name
  
	  	 
	 	 	  	 
	 	Signature	  	 
	If authorized representative is a business entity, not an individual, then please print the business name in the “signature” box, an authorized
representative of the business entity must sign in the “By” box and print their name in the “Print Name” box.	 		 		  	 
	 	 	  	 
	 	 By (if applicable)
  
	  	 
	 	 	 	 	 	  	 
	 	 	 	Print Name	  	 

  

					
	Form 540	  	Page 3 of 4	  	Last Revised: 06/2019

 ATTACHMENT TO CERTIFICATE OF AMENDMENT 

TO THE THIRD AMENDED AND RESTATED ARTICLES OF INCORPORATION 

OF KEYCORP 

RESOLVED, that pursuant to the authority granted to and vested in the pricing subcommittee (the “Subcommittee”) of the
Risk Committee (the “Committee”) of the Board of Directors of KeyCorp (the “Corporation”), pursuant to authority conferred upon the Subcommittee by resolutions of the Board of Directors of the Corporation adopted by
unanimous written consent on July 6, 2022, and resolutions of the Committee adopted at a meeting held on August 17, 2022, and in accordance with Section 1701.70(B)(1) of the Ohio Revised Code and Article IV of the Corporation’s
Third Amended and Restated Articles of Incorporation, as amended (the “Articles”), the Subcommittee hereby establishes the terms of the Corporation’s Fixed Rate Reset Perpetual
Non-Cumulative Preferred Stock, Series H, $1.00 par value per share, and fixes and determines the authorized number of shares of the series and the dividend rate of the shares of the series, with such
designations, and certain other preferences, and relative, participating, optional or other special rights, and the qualifications, limitations and restrictions thereof as previously established by the Committee, with the Articles hereby amended to
add such terms as Part L of Article IV of the Articles as set forth below: 
 PART L 

EXPRESS TERMS OF FIXED RATE RESET PERPETUAL NON-CUMULATIVE PREFERRED STOCK, SERIES H 

Section 1. Designation. The distinctive serial designation of such series shall be “Fixed Rate Reset Perpetual Non-Cumulative Preferred Stock, Series H” (“Series H”). Each share of Series H shall be identical in all respects to every other share of Series H. Series H will rank (i) equally with
Parity Stock, if any, with respect to the payment of dividends and the distribution of assets in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation and (ii) senior to Junior Stock
with respect to the payment of dividends or the distribution of assets in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation. 

Section 2. Number of Shares. The number of authorized shares of Series H shall be 600,000. Such number may from time to time be increased
(but not in excess of the total number of authorized shares of all preferred stock minus the total number of authorized shares of other series of Preferred Stock) or decreased (but not below the number of shares of Series H then outstanding) by the
Board of Directors of the Corporation or any duly authorized committee of the Board of Directors of the Corporation. Shares of Series H that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to
authorized but unissued shares of Preferred Stock undesignated as to series, and available for subsequent issuance. 
 Section 3.
Definitions. As used herein with respect to Series H: 
 (a) “Articles of Incorporation” means the Third Amended and
Restated Articles of Incorporation of the Corporation, as may be amended from time to time, and shall include this Part L of Article IV. 

(b) “Board of Directors” means the board of directors of the Corporation. 

(c) “Business Day” means any day, other than a Saturday or Sunday, that is neither a legal holiday nor any other day on which
banking institutions and trust companies in New York, New York or Cleveland, Ohio are permitted or required by any applicable law to close. 

(d) “Calculation Agent” means such bank or other entity (which may be the Corporation or an affiliate of the
Corporation) as may be appointed by the Corporation to act as Calculation Agent for the Series H, including any successor calculation agent duly appointed by the Corporation. 

 (e) “Common Shares” means the common shares, $1.00 par value per share, of
the Corporation. 
 (f) “Depositary Company” shall have the meaning set forth in Section 6(d) hereof. 

(g) “Dividend Payment Date” shall have the meaning set forth in Section 4(a) hereof. 

(h) “Dividend Period” shall have the meaning set forth in Section 4(a) hereof. 

(i) “DTC” means The Depository Trust Company, together with its successors and assigns. 

(j) “Federal Reserve” means the Board of Governors of the Federal Reserve System. 

(k) “First Reset Date” means December 15, 2027. 

(l) “Five-Year Treasury Rate” means, as of any Reset Date, the average of the yields on actively traded U.S. treasury
securities adjusted to constant maturity, for five-year maturities, for the five Business Days immediately preceding the Reset Dividend Determination Date for that Reset Period, appearing under the caption “Treasury Constant Maturities” in
the most recently published statistical release designated H.15 Daily Update or any successor publication which is published by the Federal Reserve as of 5:00 p.m. (Eastern Time) as of any Reset Dividend Determination Date, as determined by the
Calculation Agent in its sole discretion; provided that if no such calculation can be determined as described above, then: 
  

	 	•	 	 if the Calculation Agent determines that the treasury rate has not been discontinued, then the Calculation Agent
will use for such Reset Period a substitute base rate that it has determined is most comparable to the treasury rate; or 

  

	 	•	 	 if the Calculation Agent determines that the treasury rate has been discontinued, then the Calculation Agent will
use for such Reset Period and each successive Reset Period a substitute or successor base rate that it has determined is most comparable to the treasury rate; provided that, if the Calculation Agent determines there is an industry-accepted successor
base rate to the treasury rate, then the Calculation Agent shall use such successor base rate. 

 If the Calculation Agent
has determined a substitute or successor base rate in accordance with second bullet point immediately above but no calculation with respect to such substitute or successor base rate can be determined as of any subsequent Reset Dividend Determination
Date, then a new substitute or successor base rate shall be determined as set forth in the first or second bullet point immediately above, as applicable, as if the previously-determined substitute or successor base rate was the treasury rate. If the
Calculation Agent has determined a substitute or successor base rate, then the Calculation Agent will apply any technical, administrative or operational changes that the Corporation determines (including changes to the definitions of “Dividend
Period,” “Reset Period,” “Reset Date” and “Reset Dividend Determination Date,” timing and frequency of determining rates with respect to each Reset Period and making payments of dividends, rounding of amounts or
tenors, and other administrative matters) for calculating such substitute or successor base rate in a manner that is consistent with market practice for such substitute or successor base rate, including any adjustment factor needed to make such
substitute or successor base rate comparable to the treasury rate; provided that, if the Corporation decides that adoption of any portion of such market practice is not administratively feasible or if the Corporation determines that no market
practice for use of the substitute or successor base rate exists, the Calculation Agent will apply any such changes for calculating such substitute or successor base rate in such other manner as the Corporation determines is reasonably necessary.

 The Five-Year Treasury Rate shall be determined by the Calculation Agent on the Reset Dividend Determination Date. If the Five-Year
Treasury Rate for any Dividend Period cannot be determined pursuant to the methods described in the first and second bullet points above, the dividend rate for such Dividend Period shall be the same as the dividend rate determined for the
immediately preceding Dividend Period. 

  
 2 

 (m) “Junior Stock” means the Common Shares and any other class or series of
stock of the Corporation hereafter authorized over which Series H has preference or priority in the payment of dividends or in the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the
Corporation. 
 (n) “Parity Stock” means any other class or series of stock of the Corporation, including the shares of
preferred stock of the Corporation designated as Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock, Series D; Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock, Series E; Fixed Rate Perpetual
Non-Cumulative Preferred Stock, Series F; and Fixed Rate Perpetual Non-Cumulative Preferred Stock, Series G, that ranks equally with Series H in the payment of dividends
and in the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation. 

(o) “Redemption Price” shall have the meaning set forth in Section 6(a) hereof. 

(p) “Regulations” means the Third Amended and Restated Regulations of the Corporation, as amended, as may be further amended
from time to time. 
 (q) “Regulatory Capital Treatment Event” means the Corporation’s determination, in good faith,
that, as a result of any: 
  

	 	(i)	 amendment to, clarification of or change in (including any announced prospective amendment to, clarification of
or change in), the laws or regulations or policies of the United States or any political subdivision of or in the United States that is enacted or announced or that becomes effective after the initial issuance of any share of Series H;

  

	 	(ii)	 proposed amendment to or change in those laws or regulations or policies that is announced or becomes effective
after the initial issuance of any share of Series H; or 

  

	 	(iii)	 official administrative decision or judicial decision or administrative action or other official pronouncement
interpreting or applying those laws or regulations or policies that is announced or that becomes effective after the initial issuance of any share of Series H, 

there is more than an insubstantial risk that the Corporation will not be entitled to treat the full liquidation value of all shares of Series H then
outstanding as “additional tier 1 capital” (or its equivalent) for purposes of the capital adequacy guidelines or regulations of Federal Reserve, as then in effect and applicable, for as long as any share of Series H is outstanding. 

(r) “Reset Date” means the First Reset Date and each date falling on the fifth anniversary of the preceding Reset
Date, which in each case, shall not be adjusted for Business Days. 
 (s) “Reset Dividend Determination Date” means
the third Business Day immediately preceding the Reset Date. 
 (t) “Reset Period” means the period from, and
including, the First Reset Date to, but excluding, the next following Reset Date and thereafter each period from, and including, each Reset Date to, but excluding, the next following Reset Date. 

(u) “Series H” shall have the meaning set forth in Section 1 hereof. 

Section 4. Dividends. 
 (a)
Rate. Dividends on the Series H will not be mandatory. Holders of Series H shall be entitled to receive, if, as and when declared by the Board of Directors of the Corporation or any duly authorized committee of the Board of Directors of the
Corporation, but only out of assets legally available therefor, non-cumulative cash dividends on the 

  
 3 

 
liquidation preference of $1,000.00 per share of Series H, quarterly in arrears, on each March 15, June 15, September 15 and December 15, commencing December 15, 2022
(each, a “Dividend Payment Date”). Dividends shall accrue at an annual rate equal to (i) 6.200% per annum on the liquidation preference of $1,000.00 per share from the original issue date to, but excluding, the First Reset Date and
(ii) from, and including, the First Reset Date, during each Reset Period, a rate per annum equal to the Five-Year Treasury Rate as of the most recent Reset Date, plus 3.132% on the liquidation preference of $1,000.00 per share. If the
Corporation issues additional shares of the Series H after the original issue date, dividends on such shares may accrue from the original issue or any other date specified by the Board of Directors or any duly authorized committee of the Board of
Directors at the time such additional shares are issued. In the event that any Dividend Payment Date falls on a date that is not a Business Day, then payment of any dividend payable on such date will be made on the next succeeding Business Day
(without interest or other payment in respect of such delay). The period from, and including, any Dividend Payment Date to, but excluding, the next succeeding Dividend Payment Date is a “Dividend Period”; provided, however,
that the initial Dividend Period shall be the period from, and including, the date of original issuance of the Series H to, but excluding, December 15, 2022. The record date for payment of dividends on the Series H on a Dividend Payment Date
shall be the 15th calendar day before such Dividend Payment Date (provided, however, that if any such day is not a Business Day, then the record date will be the next succeeding day that is a Business Day) or such other date as determined by
the Board of Directors of the Corporation or any duly authorized committee of the Board of Directors of the Corporation. On such Dividend Payment Date, dividends shall be paid to the holder of record, as they appear on the Corporation’s stock
register on the applicable record date. The amount of dividends payable for any Dividend Period, including dividends payable for any partial Dividend Period, shall be calculated on the basis of a 360-day year
consisting of twelve 30-day months. Dividends on the Series H will cease to accrue on the redemption date, if any, with respect to the Series H redeemed, unless the Corporation defaults in the payment of the
redemption price of the Series H called for redemption. Dollar amounts resulting from that calculation will be rounded to the nearest cent, with one-half cent being rounded upward. Notwithstanding any other
provision hereof, dividends on the Series H shall not be declared, paid or set aside for payment to the extent such act would cause the Corporation to fail to comply with laws, rules and regulations applicable thereto, including applicable
regulatory capital rules. 
 (b) Noncumulative Dividends. Dividends on shares of Series H shall be
non-cumulative. To the extent that any dividends payable on the shares of Series H on any Dividend Payment Date are not declared and paid, in full or otherwise, on such Dividend Payment Date, then such
dividends shall not be cumulative and shall not be payable for such Dividend Period, and the Corporation shall have no obligation to pay, and the holders of Series H shall have no right to receive, dividends for such Dividend Period after the
Dividend Payment Date for such Dividend Period or interest with respect to such dividends, whether or not dividends are declared for any subsequent Dividend Period with respect to Series H, Parity Stock, Junior Stock or any other class or series of
authorized preferred stock of the Corporation. No interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not declared. 

(c) Priority of Dividends. So long as any share of Series H remains outstanding, (i) no dividend shall be declared or paid or set
aside for payment and no distribution shall be declared or made or set aside for payment on any Junior Stock (other than a dividend payable solely in Junior Stock, or any dividend or distribution of capital stock or rights to acquire capital stock
of the Corporation in connection with a shareholders’ rights plan or any redemption or repurchase of capital stock or rights to acquire capital stock under any such plan) and (ii) no shares of Junior Stock shall be repurchased, redeemed or
otherwise acquired for consideration by the Corporation, directly or indirectly (other than (A) as a result of a reclassification of Junior Stock for or into other Junior Stock, (B) the exchange or conversion of one share of Junior Stock
for or into another share of Junior Stock, (C) through the use of the proceeds of a substantially contemporaneous sale of other shares of Junior Stock, (D) purchases, redemptions or other acquisitions of shares of Junior Stock pursuant to
any employment contract, benefit plan or other similar arrangement with or for the benefit of employees, officers, directors or consultants, (E) purchases of shares of Junior Stock pursuant to a contractually binding requirement to buy Junior
Stock existing prior to or during the most recent preceding Dividend Period for which the full dividends for the then most recently completed Dividend Period on all outstanding shares of Series H have been declared and paid or declared and a sum
sufficient for the payment thereof has been set aside, including under a contractually binding stock repurchase plan, or (F) the purchase of fractional interests in shares of Junior Stock pursuant to the conversion or exchange provisions of
such stock or the security being converted or exchanged), nor shall any monies be paid to or made available for a sinking fund for the redemption of any such securities by the Corporation; unless, in each case, the full dividends on all outstanding

  
 4 

 
shares of Series H for the then most recently completed Dividend Period have been declared and paid in full (or declared and a sum sufficient for the payment in full thereof has been set aside
for such payment). When dividends are not paid in full upon the shares of Series H and any Parity Stock, all dividends declared upon shares of Series H and any such Parity Stock shall be declared on a proportional basis. For purposes of calculating
the proportional allocation of partial dividend payments, the Corporation shall allocate dividend payments based on the ratio between the then-current dividends due on the shares of the Series H and (i) in the case of any series of Parity Stock
that is non-cumulative preferred stock, the aggregate of the current and unpaid dividends due on such series of preferred stock, and (ii) in the case of any series of Parity Stock that is cumulative
preferred stock, the aggregate of the current and accumulated and unpaid dividends due on such series of preferred stock. No interest will be payable in respect of any declared but unpaid dividend payment on shares of Series H that is paid after the
relevant Dividend Payment Date for such Dividend Period. If the Board of Directors of the Corporation or any duly authorized committee of the Board of Directors of the Corporation determines not to pay any dividend or a full dividend on the Series H
on a Dividend Payment Date, the Corporation will provide, or cause to be provided, written notice (which may be in the form of a press release or other public announcement) to the holders of the Series H prior to such date. Subject to the foregoing,
and not otherwise, such dividends (payable in cash, stock or otherwise) as may be determined by the Board of Directors of the Corporation or any duly authorized committee of the Board of Directors of the Corporation may be declared and paid on any
Junior Stock and any Parity Stock from time to time out of any assets legally available therefor, and the holders of shares of Series H shall not be entitled to participate in any such dividend. 

Section 5. Liquidation Rights. 

(a) Voluntary or Involuntary Liquidation. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the
affairs of the Corporation, holders of Series H shall be entitled, out of assets legally available therefor, before any distribution of the assets of the Corporation may be made to the holders of any Junior Stock, and subject to the rights of the
holders of any class or series of securities ranking senior to the Series H upon liquidation and the rights of the Corporation’s depositors and other creditors, to receive in full a liquidating distribution in the amount of the liquidation
preference of $1,000.00 per share, plus any declared and unpaid dividends, without regard to any undeclared dividends. The holders of Series H shall not be entitled to any other amounts in the event of any such voluntary or involuntary liquidation,
dissolution or winding up of the affairs of the Corporation other than what is expressly provided for in this Section 5. 
 (b)
Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation are not sufficient to pay in full the liquidation preference plus any declared and unpaid dividends in full to all holders of Series H and
all holders of any Parity Stock ranking equally as to such distribution with the Series H, the amounts paid to the holders of Series H and to the holders of all such other Parity Stock shall be paid pro rata in accordance with the respective
aggregate liquidation preferences plus any declared and unpaid dividends on the Series H and all such Parity Stock. 
 (c) Residual
Distributions. If the liquidation preference plus any declared and unpaid dividends has been paid in full to all holders of Series H and all holders of any Parity Stock ranking equally as to such distribution with the Series H, the holders of
Junior Stock shall be entitled to receive all remaining assets of the Corporation according to their respective rights and preferences. 

(d) Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the sale, lease or exchange (for
cash, securities or other property) of all or substantially all of the property and assets of the Corporation shall not constitute a voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation, nor shall the
merger, consolidation or any other business combination transaction of the Corporation into or with any other entity or the merger, consolidation or any other business combination transaction of any other entity into or with the Corporation in which
the holders of Series H receive cash, securities or other property for their shares of Series H, constitute a voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation. 

  
 5 

 Section 6. Redemption. 

(a) Optional Redemption. The Corporation, at the option of its Board of Directors or any duly authorized committee of the Board of
Directors of the Corporation and subject to prior Federal Reserve approval, may redeem in whole or in part the shares of Series H at the time outstanding, on the Dividend Payment Date on December 15, 2027, or on any Dividend Payment Date
thereafter, upon notice given as provided in Section 6(b) below. The redemption price for shares of Series H shall be $1,000.00 per share plus dividends that have been declared but not paid, without regard to, or payment of, any undeclared
dividends (the “Redemption Price”). Notwithstanding the foregoing, at any time within 90 days following the occurrence of a Regulatory Capital Treatment Event, the Corporation, at its option and subject to prior Federal Reserve
approval, may provide notice of its intent to redeem, as provided in Section 6(b) below, and subsequently redeem, all (but not less than all) of the shares of Series H at the time outstanding at the Redemption Price applicable on such date of
redemption. 
 (b) Notice of Redemption. Notice of every redemption of shares of Series H shall be either (1) mailed by first
class mail, postage prepaid, addressed to the holders of record of such shares to be redeemed at their respective last addresses appearing on the stock register of the Corporation or (2) transmitted by such other method approved by the
Depositary Company, in its reasonable discretion, to the holders of record of such shares to be redeemed. Such mailing or transmittal shall not be less than 30 days and not more than 60 days before the date fixed for redemption. Notwithstanding the
foregoing, if the Series H is held in book-entry form through DTC, the Corporation may give such notice in any manner permitted by DTC. Any notice provided pursuant to this Section 6(b) shall be conclusively presumed to have been duly given,
whether or not the holder receives such notice, but failure duly to provide such notice, or any defect in such notice or in the provision thereof, to any holder of shares of Series H designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series H. Each notice shall state (i) the redemption date; (ii) the number of shares of Series H to be redeemed and, if less than all the shares held by such holder are to be redeemed,
the number of such shares to be redeemed from such holder (or the method of determining such number); (iii) the Redemption Price; (iv) the place or places where the certificates evidencing such shares of Series H are to be surrendered for
payment of the Redemption Price; and (v) that dividend rights on the shares to be redeemed will cease on the redemption date. 
 (c)
Partial Redemption. In case of any redemption of only part of the shares of Series H at the time outstanding, the shares of Series H to be redeemed shall be selected either pro rata from the holders of record of Series H in proportion to the
number of Series H held by such holders or by lot, provided that if the Series H is held in book-entry form through DTC, such shares may be selected in any manner required by DTC. Subject to the provisions of this Section 6, the Board of
Directors of the Corporation or any duly authorized committee of the Board of Directors shall have full power and authority to prescribe the terms and conditions upon which shares of Series H shall be redeemed from time to time. 

(d) Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the redemption date specified in the
notice all funds necessary for the redemption have been set aside by the Corporation, separate and apart from its other assets, for the benefit of the holders of the shares called for redemption, so as to be and continue to be available therefor, or
deposited by the Corporation with a bank or trust company selected by the Board of Directors of the Corporation or any duly authorized committee of the Board of Directors (the “Depositary Company”) for the benefit of the holders of
the shares called for redemption, then, notwithstanding that any certificate for any share so called for redemption has not been surrendered for cancellation, on and after the redemption date all shares so called for redemption shall cease to be
outstanding, all dividend rights with respect to such shares will cease on the redemption date, and all rights with respect to such shares shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to
receive the amount payable on such redemption from the trust fund set aside by the Corporation or from the bank or trust company where the funds have been deposited at any time after the redemption date from such funds, without interest. The
Corporation shall be entitled to receive, from time to time, from the Depositary Company any interest accrued on such funds, and the holders of any shares called for redemption shall have no claim to any such interest. Any funds so deposited and
unclaimed at the end of three years from the redemption date shall, to the extent permitted by law, be released or repaid to the Corporation, and in the event of such repayment to the Corporation, the holders of record of the shares so called for
redemption shall be deemed to be unsecured creditors of the Corporation for an amount equivalent to the amount deposited as stated above for the redemption of such shares and so repaid to the Corporation, but shall in no event be entitled to any
interest. 

  
 6 

 Section 7. Voting Rights. The holders of Series H shall not have any voting rights except
as expressly provided in the Articles of Incorporation, including Section 2 of Part A of Article IV, and except as shall be affirmatively provided in the Ohio General Corporation Law. 

Section 8. Conversion. The holders of Series H shall not have any rights to convert such Series H into shares of any other class of capital
stock of the Corporation. 
 Section 9. Rank. Notwithstanding anything set forth in the Articles of Incorporation or the Regulations to
the contrary, the Board of Directors of the Corporation or any duly authorized committee of the Board of Directors of the Corporation, without the vote of the holders of the Series H, may authorize and issue additional shares of Junior Stock, Parity
Stock or, subject to the voting rights granted in Section 2(e)(i) of Part A of Article IV, any class of securities ranking senior to the Series H as to dividends and the distribution of assets upon any voluntary or involuntary liquidation,
dissolution or winding up of the affairs of the Corporation. 
 Section 10. Repurchase. The Corporation may purchase Series H from time
to time to such extent, in such manner, and upon such terms as the Board of Directors of the Corporation or any duly authorized committee of the Board of Directors of the Corporation may determine, subject to any required prior Federal Reserve
approval; provided, however, that the Corporation shall not use any of its funds for any such purchase when there are reasonable grounds to believe that the Corporation is, or by such purchase would be, rendered insolvent or the funds are
otherwise not legally available therefor under applicable law. 
 Section 11. No Sinking Fund. The Series H will not be subject to any
mandatory redemption, sinking fund or other similar provisions. Holders of Series H will have no right to require redemption or repurchase of any shares of Series H. 

Section 12. Record Holders. To the fullest extent permitted by applicable law, the Corporation and any transfer agent for the Series H may
deem and treat the record holder of any share of Series H as the true and lawful owner thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary. 

Section 13. Notices. All notices or communications in respect of the Series H shall be sufficiently given if given in writing and delivered
in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in the Articles of Incorporation or Regulations or by applicable law. 

Section 14. No Preemptive Rights. No share of Series H shall have any rights of preemption whatsoever as to any securities of the
Corporation, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted. 

Section 15. Other Rights. The shares of Series H shall not have any voting powers, preferences or relative, participating, optional or
other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein or in the Articles of Incorporation or as provided by applicable law. 

Section 16. Certificates. The Corporation may at its option issue shares of Series H without certificates. 

****** 

  
 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]